Why the study?
Can a modified cone and plate(let) analyzer (CPA) test effectively evaluate the efficacy of anti-platelet therapy?
Population
Blood samples from untreated healthy volunteers and volunteers treated with 100, 300, and 500 mg aspirin per…
Comparison
Modified cone and plate analyzer test using… vs Standard aggregometry and baseline samples
Design
Other
Authors
Loading...
Modified CPA may enable point-of-care aspirin monitoring; leaves open clinical utility versus aggregometry in patients.
Can a modified cone and plate(let) analyzer (CPA) test effectively evaluate the efficacy of anti-platelet therapy?
The modified CPA test is a potentially useful point-of-care tool for monitoring the efficacy of anti-platelet therapy.
Spectre et al. (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: